McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical pro...

McKesson Corporation (MCK) has a valuation score of 100/100 (strong), profitability score of 26/100 (weak), financial health score of 76/100 (strong), Piotroski F-Score of 6/9, Altman Z-Score of 6.17 (safe zone), revenue growth of +13.4% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 2, 2026

Analyst Recommendations24 analysts · 2026-09-01
8
11
5
Strong Buy 8Buy 11Hold 5Sell 0Strong Sell 0

Recent Market Moves

See all MCK moves →
DateSessionPriceMoveZ-Score
Aug 26Pre-market$905.09+3.58%2.39
Aug 25Regular$900.50+3.06%2.04
Aug 25After-hours$905.09+3.58%2.39
Aug 5Regular$861.08+3.69%2.46
Aug 5After-hours$892.00+7.41%4.94